Hemodynamic Response to Lipopolysaccharide Infusion and Effect of Meloxicam Administration on Cardiac Function in Donkeys

Francisco J. Mendoza, Antonio Buzon-Cuevas, Raul Aguilera-Aguilera, Carlos A. Gonzalez-De Cara, Adelaida De Las Heras, Alejandro Perez-Ecija · 2024

Read Hemodynamic Response to Lipopolysaccharide Infusion and Effect of Meloxicam Administration on Cardiac Function in Donkeys by Francisco J. Mendoza, Antonio Buzon-Cuevas, Raul Aguilera-Aguilera, Carlos A. Gonzalez-De Cara, Adelaida De Las Heras, Alejandro Perez-Ecija (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11672460.txt.

Description

Francisco Mendoza and co-authors test, in a 2024 veterinary study, how a bacterial toxin hits the donkey heart, and whether a common pain drug can block the harm. Endotoxemia drives the body-wide inflammation that follows colic and gut disease in equines. Horses suffer clear heart and pressure trouble from it, but donkeys had never been tested. Six healthy jennies got a toxin infusion under close watch for six hours.

The toxin raised a heart injury marker in the blood, dropped blood pressure and vein pressure, and weakened the heart's pumping on ultrasound. A dose of meloxicam, an anti-inflammatory, prevented nearly all of it: no injury marker rise, steadier pressure, and a protected heartbeat. The authors propose the drug as a real option for donkeys in this dangerous state.

Catalog record

CREATORFrancisco J. Mendoza, Antonio Buzon-Cuevas, Raul Aguilera-Aguilera, Carlos A. Gonzalez-De Cara, Adelaida De Las Heras, Alejandro Perez-Ecija
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE26 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11672460

Browse the full library · About the Tower of Babel